Pulmonary Tuberculoses
Conditions
Brief summary
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree
Detailed description
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree. The prevalence of bronchiectasis is age-related and occurs in every age group and in the pre-antibiotic era . it most often began in childhood. Recent evidence shows that bronchiectasis disproportionately affects women and older individuals and will be contributing to increase in healthcare burden.\[3\] International data show an increase in the prevalence of bronchiectasis over recent years.
Interventions
DIAGNOSTIC_TESTGene Xpert Chest x ray and MSCT chest
Sputum sample for T.B will be done using gene expert device and chest xray and high resolution ct to evaluate bronchectasis
Sponsors
Assiut University
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Inclusion criteria
* 1-patients were diagnosed to have tuberculosis by sputum culture and gene x pert. 2-patients were diagnosed to have bronchiectasis after lab and radiological examination as well as clinical score. 3- patients diagnosed as bronchiectasis after history of tuberculosis or anti Tuberculosis treatment with positive or negative tuberculous culture in the time of research.
Exclusion criteria
* 1-patients presented with other Pulmonary diseases. 2-Chronic liver and renal disease . 3- Lung cancer and tumors. 4- patients were previously diagnosed as bronchiectasis .
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To study prevalence of bronchiectasis in TB patients by case per year. | One year | How many patients of TB will be diagnosed as abronchiectasis |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To evaluate the burden of bronchiectasis in TB patients | one year | by frequency of need for hospital admission per year, need for outpatient clinical visits per month and frequency of need for antimicrobial therapy other than anti-tuberculous treatment per month |
Countries
Egypt
Outcome results
None listed